US Patent

US8802142 — Pharmaceutical compositions comprising levetiracetam and process for their preparation

Formulation · Assigned to UCB SA · Expires 2031-06-07 · 5y remaining

Vulnerability score 53/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a pharmaceutical composition containing levetiracetam and a process for its preparation with specific percentages of disintegrant, gliding agent, binder, and lubricant.

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient and 2.0 to 9.0% per weight of disintegrant, 0.0 to 3.0% per weight of gliding agent, 0.5 to 6.0% per weight of binder, and 0.0 to 1.0% per weight of lubricant, with respect to the total weight of the pharmaceutical composition, and to a process for its preparation.

Drugs covered by this patent

Patent Metadata

Patent number
US8802142
Jurisdiction
US
Classification
Formulation
Expires
2031-06-07
Drug substance claim
No
Drug product claim
Yes
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.